
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metformin effect on gut microbiota: insights for HIV-related inflammation
Jing Ouyang, Stéphane Isnard, John Lin, et al.
AIDS Research and Therapy (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 52
Jing Ouyang, Stéphane Isnard, John Lin, et al.
AIDS Research and Therapy (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 52
Showing 1-25 of 52 citing articles:
The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System
Gholamreza Daryabor, Mohammad Reza Atashzar, Dieter Kabelitz, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 446
Gholamreza Daryabor, Mohammad Reza Atashzar, Dieter Kabelitz, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 446
Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis
Pan Luo, Lin Qiu, Yi Liu, et al.
American Journal of Tropical Medicine and Hygiene (2020) Vol. 103, Iss. 1, pp. 69-72
Open Access | Times Cited: 256
Pan Luo, Lin Qiu, Yi Liu, et al.
American Journal of Tropical Medicine and Hygiene (2020) Vol. 103, Iss. 1, pp. 69-72
Open Access | Times Cited: 256
Treatment with camu camu (Myrciaria dubia) prevents obesity by altering the gut microbiota and increasing energy expenditure in diet-induced obese mice
Fernando F. Anhê, Renato Tadeu Nachbar, Thibault Varin, et al.
Gut (2018) Vol. 68, Iss. 3, pp. 453-464
Open Access | Times Cited: 242
Fernando F. Anhê, Renato Tadeu Nachbar, Thibault Varin, et al.
Gut (2018) Vol. 68, Iss. 3, pp. 453-464
Open Access | Times Cited: 242
Human trials exploring anti-aging medicines
Leonard Guarente, David Sinclair, Guido Kroemer
Cell Metabolism (2024) Vol. 36, Iss. 2, pp. 354-376
Open Access | Times Cited: 75
Leonard Guarente, David Sinclair, Guido Kroemer
Cell Metabolism (2024) Vol. 36, Iss. 2, pp. 354-376
Open Access | Times Cited: 75
Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System
Xiaorong Peng, Jing Ouyang, Stéphane Isnard, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 111
Xiaorong Peng, Jing Ouyang, Stéphane Isnard, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 111
The Bacterium Akkermansia muciniphila: A Sentinel for Gut Permeability and Its Relevance to HIV-Related Inflammation
Jing Ouyang, John Lin, Stéphane Isnard, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 106
Jing Ouyang, John Lin, Stéphane Isnard, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 106
The Fatty Acid Lipid Metabolism Nexus in COVID-19
Jerome E. Tanner, Caroline Alfieri
Viruses (2021) Vol. 13, Iss. 1, pp. 90-90
Open Access | Times Cited: 70
Jerome E. Tanner, Caroline Alfieri
Viruses (2021) Vol. 13, Iss. 1, pp. 90-90
Open Access | Times Cited: 70
Mechanism of metformin regulation in central nervous system: Progression and future perspectives
Gui Cao, Ting Gong, Yue Du, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113686-113686
Open Access | Times Cited: 54
Gui Cao, Ting Gong, Yue Du, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113686-113686
Open Access | Times Cited: 54
Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study
Yang Du, Yajuan Zhu, Yixin Zhou, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 42
Yang Du, Yajuan Zhu, Yixin Zhou, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 42
Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection
Silvère D. Zaongo, Jing Ouyang, Stéphane Isnard, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 33
Silvère D. Zaongo, Jing Ouyang, Stéphane Isnard, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 33
ACE2, Metformin, and COVID-19
Atul Malhotra, Mark Hepokoski, Karen C. McCowen, et al.
iScience (2020) Vol. 23, Iss. 9, pp. 101425-101425
Open Access | Times Cited: 61
Atul Malhotra, Mark Hepokoski, Karen C. McCowen, et al.
iScience (2020) Vol. 23, Iss. 9, pp. 101425-101425
Open Access | Times Cited: 61
LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy
Delphine Planas, Amélie Pagliuzza, Rosalie Ponte, et al.
EBioMedicine (2021) Vol. 65, pp. 103270-103270
Open Access | Times Cited: 55
Delphine Planas, Amélie Pagliuzza, Rosalie Ponte, et al.
EBioMedicine (2021) Vol. 65, pp. 103270-103270
Open Access | Times Cited: 55
Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential
Oleksandr Kamyshnyi, V. M. Matskevych, Tetyana Lenchuk, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112230-112230
Open Access | Times Cited: 55
Oleksandr Kamyshnyi, V. M. Matskevych, Tetyana Lenchuk, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112230-112230
Open Access | Times Cited: 55
Does metformin affect outcomes in COVID‐19 patients with new or pre‐existing diabetes mellitus? A systematic review and meta‐analysis
Adithan Ganesh, Michael D. Randall
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 6, pp. 2642-2656
Open Access | Times Cited: 35
Adithan Ganesh, Michael D. Randall
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 6, pp. 2642-2656
Open Access | Times Cited: 35
Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
Awadhesh Kumar Singh, Ritu Singh
Diabetes Research and Clinical Practice (2020) Vol. 165, pp. 108268-108268
Open Access | Times Cited: 40
Awadhesh Kumar Singh, Ritu Singh
Diabetes Research and Clinical Practice (2020) Vol. 165, pp. 108268-108268
Open Access | Times Cited: 40
A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin
Jamie N. Justice, Sriram Gubbi, Ameya Kulkarni, et al.
GeroScience (2020) Vol. 43, Iss. 3, pp. 1093-1112
Open Access | Times Cited: 40
Jamie N. Justice, Sriram Gubbi, Ameya Kulkarni, et al.
GeroScience (2020) Vol. 43, Iss. 3, pp. 1093-1112
Open Access | Times Cited: 40
Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
Varda Shoshan‐Barmatz, Uttpal Anand, Edna Nahon-Crystal, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 34
Varda Shoshan‐Barmatz, Uttpal Anand, Edna Nahon-Crystal, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 34
Repurposing Metformin in Nondiabetic People With HIV: Influence on Weight and Gut Microbiota
Stéphane Isnard, John Lin, Brandon Fombuena, et al.
Open Forum Infectious Diseases (2020) Vol. 7, Iss. 9
Open Access | Times Cited: 39
Stéphane Isnard, John Lin, Brandon Fombuena, et al.
Open Forum Infectious Diseases (2020) Vol. 7, Iss. 9
Open Access | Times Cited: 39
GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin
Jing Ouyang, Stéphane Isnard, John Lin, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 34
Jing Ouyang, Stéphane Isnard, John Lin, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 34
Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature
Awadhesh Kumar Singh, Ritu Singh, Banshi Saboo, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 15, Iss. 1, pp. 159-167
Open Access | Times Cited: 34
Awadhesh Kumar Singh, Ritu Singh, Banshi Saboo, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 15, Iss. 1, pp. 159-167
Open Access | Times Cited: 34
Kynurenine pathway in type 2 diabetes: Role of metformin
Zainah Al‐Qahtani, Hayder M. Al‐kuraishy, Naif H. Ali, et al.
Drug Development Research (2024) Vol. 85, Iss. 5
Open Access | Times Cited: 4
Zainah Al‐Qahtani, Hayder M. Al‐kuraishy, Naif H. Ali, et al.
Drug Development Research (2024) Vol. 85, Iss. 5
Open Access | Times Cited: 4
Metformin inhibits EV-A71 and CVA16 infections by regulating TRIB3-SCARB2 axis and activating AMPK
Huiqiang Wang, Boming Cui, Haiyan Yan, et al.
Antiviral Research (2025) Vol. 235, pp. 106081-106081
Closed Access
Huiqiang Wang, Boming Cui, Haiyan Yan, et al.
Antiviral Research (2025) Vol. 235, pp. 106081-106081
Closed Access
Frailty and HIV: Moving from Characterization to Intervention
Kristine M. Erlandson, Damani A. Piggott
Current HIV/AIDS Reports (2021) Vol. 18, Iss. 3, pp. 157-175
Open Access | Times Cited: 25
Kristine M. Erlandson, Damani A. Piggott
Current HIV/AIDS Reports (2021) Vol. 18, Iss. 3, pp. 157-175
Open Access | Times Cited: 25
Mechanisms of immune aging in HIV
Manon Chauvin, Delphine Sauce
Clinical Science (2022) Vol. 136, Iss. 1, pp. 61-80
Open Access | Times Cited: 18
Manon Chauvin, Delphine Sauce
Clinical Science (2022) Vol. 136, Iss. 1, pp. 61-80
Open Access | Times Cited: 18
HIV and comorbidities – the importance of gut inflammation and the kynurenine pathway
Rachel MacCann, Alan Landay, Patrick Mallon
Current Opinion in HIV and AIDS (2022) Vol. 18, Iss. 2, pp. 102-110
Open Access | Times Cited: 15
Rachel MacCann, Alan Landay, Patrick Mallon
Current Opinion in HIV and AIDS (2022) Vol. 18, Iss. 2, pp. 102-110
Open Access | Times Cited: 15